Nano‐formulated drugs in oral carcinomas

Q3 Dentistry

Oral Surgery Pub Date : 2023-09-22 DOI:10.1111/ors.12853

Ankita Mathur, Snehasish Tripathy, Vini Mehta

{"title":"Nano‐formulated drugs in oral carcinomas","authors":"Ankita Mathur, Snehasish Tripathy, Vini Mehta","doi":"10.1111/ors.12853","DOIUrl":null,"url":null,"abstract":"Oral SurgeryEarly View LETTER TO THE EDITOR Nano-formulated drugs in oral carcinomas Ankita Mathur, Ankita Mathur Department of Dental Research Cell, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pune, IndiaSearch for more papers by this authorSnehasish Tripathy, Snehasish Tripathy Department of Dental Research Cell, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pune, IndiaSearch for more papers by this authorVini Mehta, Corresponding Author Vini Mehta [email protected] orcid.org/0000-0003-4174-907X Department of Dental Research Cell, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pune, India Correspondence Vini Mehta, Department of Dental Research Cell, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune 411018, India. Email: [email protected]Search for more papers by this author Ankita Mathur, Ankita Mathur Department of Dental Research Cell, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pune, IndiaSearch for more papers by this authorSnehasish Tripathy, Snehasish Tripathy Department of Dental Research Cell, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pune, IndiaSearch for more papers by this authorVini Mehta, Corresponding Author Vini Mehta [email protected] orcid.org/0000-0003-4174-907X Department of Dental Research Cell, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pune, India Correspondence Vini Mehta, Department of Dental Research Cell, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune 411018, India. Email: [email protected]Search for more papers by this author First published: 22 September 2023 https://doi.org/10.1111/ors.12853Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Sahu T, Ratre YK, Chauhan S, Bhaskar LVKS, Nair MP, Verma HK. Nanotechnology based drug delivery system: current strategies and emerging therapeutic potential for medical science. J Drug Deliv Sci Technol. 2021; 63:102487. https://doi.org/10.1016/j.jddst.2021.102487 2Zhang Y, Li M, Gao X, Chen Y, Liu T. Nanotechnology in cancer diagnosis: progress, challenges and opportunities. J Hematol Oncol. 2019; 12(1): 137. https://doi.org/10.1186/s13045-019-0833-3 3Oral cancer—the fight must go on against all odds…. Evid Based Dent. 2022; 23(1): 4–5. https://doi.org/10.1038/s41432-022-0243-1 4Nakamura H, Jun F, Maeda H. Development of next-generation macromolecular drugs based on the EPR effect: challenges and pitfalls. Expert Opin Drug Deliv. 2015; 12(1): 53–64. https://doi.org/10.1517/17425247.2014.955011 5Rajora AK, Ravishankar D, Zhang H, Rosenholm JM. Recent advances and impact of chemotherapeutic and antiangiogenic nanoformulations for combination cancer therapy. Pharmaceutics. 2020; 12(6):592. https://doi.org/10.3390/pharmaceutics12060592 6Thambiraj S, Vijayalakshmi R, Ravi SD. An effective strategy for the development of docetaxel encapsulated gold nanoformulations for treatment of prostate cancer. Sci Rep. 2021; 11(1): 2808. https://doi.org/10.1038/s41598-020-80529-1 7Mansour A, Mahmoud MY, Bakr AF, Ghoniem MG, Adam FA, El-Sherbiny IM. Dual-enhanced pluronic nanoformulated methotrexate-based treatment approach for breast cancer: development and evaluation of in vitro and in vivo efficiency. Pharmaceutics. 2022; 14(12):2668. https://doi.org/10.3390/pharmaceutics14122668 8Halawani EM, Hassan AM, Gad El-Rab SMF. Nanoformulation of biogenic cefotaxime-conjugated-silver nanoparticles for enhanced antibacterial efficacy against multidrug-resistant bacteria and anticancer studies. Int J Nanomedicine. 2020; 15: 1889–1901. https://doi.org/10.2147/IJN.S236182 9Siddique S, Chow JCL. Recent advances in functionalized nanoparticles in cancer theranostics. Nanomaterials. 2022; 12(16):2826. https://doi.org/10.3390/nano12162826 10Babu A, Templeton AK, Munshi A, Ramesh R. Nanoparticle-based drug delivery for therapy of lung cancer: Progress and challenges. J Nanomater. 2013; 2013:e863951. https://doi.org/10.1155/2013/863951 11Gavas S, Quazi S, Karpiński TM. Nanoparticles for cancer therapy: current progress and challenges. Nanoscale Res Lett. 2021; 16(1): 173. https://doi.org/10.1186/s11671-021-03628-6 Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation","PeriodicalId":38418,"journal":{"name":"Oral Surgery","volume":"23 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/ors.12853","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Dentistry","Score":null,"Total":0}

引用次数: 0

Abstract

Oral SurgeryEarly View LETTER TO THE EDITOR Nano-formulated drugs in oral carcinomas Ankita Mathur, Ankita Mathur Department of Dental Research Cell, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pune, IndiaSearch for more papers by this authorSnehasish Tripathy, Snehasish Tripathy Department of Dental Research Cell, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pune, IndiaSearch for more papers by this authorVini Mehta, Corresponding Author Vini Mehta [email protected] orcid.org/0000-0003-4174-907X Department of Dental Research Cell, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pune, India Correspondence Vini Mehta, Department of Dental Research Cell, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune 411018, India. Email: [email protected]Search for more papers by this author Ankita Mathur, Ankita Mathur Department of Dental Research Cell, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pune, IndiaSearch for more papers by this authorSnehasish Tripathy, Snehasish Tripathy Department of Dental Research Cell, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pune, IndiaSearch for more papers by this authorVini Mehta, Corresponding Author Vini Mehta [email protected] orcid.org/0000-0003-4174-907X Department of Dental Research Cell, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pune, India Correspondence Vini Mehta, Department of Dental Research Cell, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune 411018, India. Email: [email protected]Search for more papers by this author First published: 22 September 2023 https://doi.org/10.1111/ors.12853Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Sahu T, Ratre YK, Chauhan S, Bhaskar LVKS, Nair MP, Verma HK. Nanotechnology based drug delivery system: current strategies and emerging therapeutic potential for medical science. J Drug Deliv Sci Technol. 2021; 63:102487. https://doi.org/10.1016/j.jddst.2021.102487 2Zhang Y, Li M, Gao X, Chen Y, Liu T. Nanotechnology in cancer diagnosis: progress, challenges and opportunities. J Hematol Oncol. 2019; 12(1): 137. https://doi.org/10.1186/s13045-019-0833-3 3Oral cancer—the fight must go on against all odds…. Evid Based Dent. 2022; 23(1): 4–5. https://doi.org/10.1038/s41432-022-0243-1 4Nakamura H, Jun F, Maeda H. Development of next-generation macromolecular drugs based on the EPR effect: challenges and pitfalls. Expert Opin Drug Deliv. 2015; 12(1): 53–64. https://doi.org/10.1517/17425247.2014.955011 5Rajora AK, Ravishankar D, Zhang H, Rosenholm JM. Recent advances and impact of chemotherapeutic and antiangiogenic nanoformulations for combination cancer therapy. Pharmaceutics. 2020; 12(6):592. https://doi.org/10.3390/pharmaceutics12060592 6Thambiraj S, Vijayalakshmi R, Ravi SD. An effective strategy for the development of docetaxel encapsulated gold nanoformulations for treatment of prostate cancer. Sci Rep. 2021; 11(1): 2808. https://doi.org/10.1038/s41598-020-80529-1 7Mansour A, Mahmoud MY, Bakr AF, Ghoniem MG, Adam FA, El-Sherbiny IM. Dual-enhanced pluronic nanoformulated methotrexate-based treatment approach for breast cancer: development and evaluation of in vitro and in vivo efficiency. Pharmaceutics. 2022; 14(12):2668. https://doi.org/10.3390/pharmaceutics14122668 8Halawani EM, Hassan AM, Gad El-Rab SMF. Nanoformulation of biogenic cefotaxime-conjugated-silver nanoparticles for enhanced antibacterial efficacy against multidrug-resistant bacteria and anticancer studies. Int J Nanomedicine. 2020; 15: 1889–1901. https://doi.org/10.2147/IJN.S236182 9Siddique S, Chow JCL. Recent advances in functionalized nanoparticles in cancer theranostics. Nanomaterials. 2022; 12(16):2826. https://doi.org/10.3390/nano12162826 10Babu A, Templeton AK, Munshi A, Ramesh R. Nanoparticle-based drug delivery for therapy of lung cancer: Progress and challenges. J Nanomater. 2013; 2013:e863951. https://doi.org/10.1155/2013/863951 11Gavas S, Quazi S, Karpiński TM. Nanoparticles for cancer therapy: current progress and challenges. Nanoscale Res Lett. 2021; 16(1): 173. https://doi.org/10.1186/s11671-021-03628-6 Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation

查看原文本刊更多论文

纳米制剂在口腔癌中的应用

口腔外科年度观点给编辑的信口腔癌中的纳米配方药物Ankita Mathur, Ankita Mathur牙科研究细胞部，Dr. D. Y. Patil牙科学院和医院，Dr. D. Y. Patil Vidyapeeth，印度浦那，搜索作者的更多论文Snehasish Tripathy，牙科研究细胞部，Dr. Y. Patil牙科学院和医院，Dr. D. Y. Patil Vidyapeeth，印度浦那，搜索作者的更多论文通讯作者Vini Mehta [email protected] orcid.org/0000-0003-4174-907X印度浦那D. Y. Patil牙科学院和医院牙科研究室，D. Y. Patil Vidyapeeth博士通讯Vini Mehta, D. Y. Patil牙科学院和医院牙科研究室，D. Y. Patil Vidyapeeth博士，浦那411018，印度。电子邮件:[email protected]搜索本作者的更多论文，Ankita Mathur, Ankita Mathur牙科研究所，Dr. Y. Patil牙科学院和医院，Dr. Y. Patil Vidyapeeth，印度浦那，搜索本作者的更多论文，Snehasish Tripathy, Snehasish Tripathy牙科研究所，Dr. Y. Patil牙科学院和医院，Dr. Y. Patil Vidyapeeth，印度浦那通讯作者Vini Mehta [email protected] orcid.org/0000-0003-4174-907X印度浦那D. Y. Patil牙科学院和医院牙科研究室，D. Y. Patil Vidyapeeth博士通讯Vini Mehta, D. Y. Patil牙科学院和医院牙科研究室，D. Y. Patil Vidyapeeth博士，浦那411018，印度。邮箱:[Email protected]搜索该作者的更多论文首次发表:2023年9月22日https://doi.org/10.1111/ors.12853Read全文taboutpdf ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare给予accessShare全文accessShare全文accessShare全文accessShare请查看我们的使用条款和条件，并勾选下面的复选框共享文章的全文版本。我已经阅读并接受了Wiley在线图书馆使用共享链接的条款和条件，请使用下面的链接与您的朋友和同事分享本文的全文版本。学习更多的知识。复制URL共享链接共享一个emailfacebooktwitterlinkedinreddit微信本文无摘要参考文献1Sahu T, Ratre YK, Chauhan S, Bhaskar LVKS, Nair MP, Verma HK。基于纳米技术的药物传递系统:当前的策略和医学科学的新治疗潜力。[J] .中国生物医学工程学报。2011;63:102487。https://doi.org/10.1016/j.jddst.2021.102487 2张勇，李敏，高翔，陈勇，刘涛。纳米技术在癌症诊断中的进展、挑战与机遇。中华血液学杂志;2019;12(1): 137。https://doi.org/10.1186/s13045-019-0833-3 3口腔癌——必须不顾一切地继续战斗....基于Evid的Dent. 2022;23(1): 4 - 5。https://doi.org/10.1038/s41432-022-0243-1 4中村浩，冯军，前田浩。基于EPR效应的新一代大分子药物的开发:挑战和缺陷。专家意见2015;12(1): 53 - 64。https://doi.org/10.1517/17425247.2014.955011 5Rajora AK, Ravishankar D，张宏，Rosenholm JM。化疗和抗血管生成纳米制剂在癌症联合治疗中的最新进展和影响。制药学,2020;12(6): 592。https://doi.org/10.3390/pharmaceutics12060592 6Thambiraj S, Vijayalakshmi R, Ravi SD。多西紫杉醇包封金纳米制剂治疗前列腺癌的有效策略。科学众议员2021;11(1): 2808。https://doi.org/10.1038/s41598-020-80529-1 7Mansour A, Mahmoud MY, Bakr AF, Ghoniem MG, Adam FA, El-Sherbiny IM。基于双增强pluronic纳米配方甲氨蝶呤的乳腺癌治疗方法:体外和体内效率的开发和评估。制药学,2022;14(12): 2668。https://doi.org/10.3390/pharmaceutics14122668 8Halawani EM, Hassan AM, Gad El-Rab SMF。生物源头孢噻肟偶联纳米银纳米制剂对多药耐药细菌的抗菌效果和抗癌研究。国际医学杂志。2020;15: 1889 - 1901。https://doi.org/10.2147/IJN.S236182 9Siddique S, Chow JCL。功能化纳米颗粒在癌症治疗中的最新进展。纳米材料。2022;12(16): 2826。https://doi.org/10.3390/nano12162826 10张建军，张建军，张建军，等。基于纳米颗粒的药物递送治疗肺癌的研究进展与挑战。纳米材料学报。2013;2013: e863951。https://doi.org/10.1155/2013/863951 11Gavas S, Quazi S, Karpiński TM。纳米粒子用于癌症治疗:目前的进展和挑战。纳米材料学报。2021;16(1): 173。https://doi.org/10.1186/s11671-021-03628-6早期视图记录在包含问题之前的在线版本参考信息

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Oral Surgery Medicine-Surgery

CiteScore

0.90

自引率

0.00%

发文量